601607 Shanghai Pharmaceuticals Holding
- 18.78
- +0.34+1.84%
Shanghai Pharmaceuticals Holding News
Announcement on the Progress of Pharmaceutical Clinical Trials by SH Pharma Group Co., Ltd.
Announcement Regarding the Consistent Evaluation of Dapantinib Tablets for Generic Drugs by SH Pharma Group Co., Ltd.
Notice of Shanghai Pharma Holding Co., Ltd. on Convening the Annual Shareholders' Meeting in 2023.
Meeting documents for the 2023 Annual Shareholders' Meeting of Sh Pharma Group Co., Ltd.
Announcement of the resolution of the seventh meeting of the eighth session of the board of supervisors of SH Pharma Group Co., Ltd.
Announcement of Shanghai Pharma Group Co., Ltd. regarding the mid-term dividend arrangement for 2024.
Announcement of Resolutions of the 10th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
202405 Shanghai Pharmaceutical Investor Relations Activity Record Form - v2
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of maxitengtan tablets
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the resignation of a director
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on I040 receiving a clinical trial approval notice
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval of the marketing application for perindopril tert-butylamine
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on holding a performance briefing for the first quarter of 2024
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on metoclopramide hydrochloride injection passing the generic drug consistency evaluation
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of sacubatl valsartan tablets
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of injectable methotrexate
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on I031 receiving a clinical trial approval notice
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of levosimendan injection
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the approval of new specifications for injectable parecoxib sodium
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the progress of drug clinical trials
Analysis
Price Target
No Data
